Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA ZYDUS LIFESCIENCES AUROBINDO PHARMA/
ZYDUS LIFESCIENCES
 
P/E (TTM) x 12.3 22.7 54.1% View Chart
P/BV x 1.1 2.8 37.6% View Chart
Dividend Yield % 2.0 0.5 383.5%  

Financials

 AUROBINDO PHARMA   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-22
ZYDUS LIFESCIENCES
Mar-22
AUROBINDO PHARMA/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs1,064674 157.9%   
Low Rs584331 176.5%   
Sales per share (Unadj.) Rs400.3149.1 268.5%  
Earnings per share (Unadj.) Rs45.722.7 201.2%  
Cash flow per share (Unadj.) Rs64.929.7 218.7%  
Dividends per share (Unadj.) Rs9.002.50 360.0%  
Avg Dividend yield %1.10.5 219.5%  
Book value per share (Unadj.) Rs419.4166.1 252.6%  
Shares outstanding (eoy) m585.941,023.74 57.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.13.4 61.1%   
Avg P/E ratio x18.022.1 81.5%  
P/CF ratio (eoy) x12.716.9 75.0%  
Price / Book Value ratio x2.03.0 64.9%  
Dividend payout %19.711.0 179.0%   
Avg Mkt Cap Rs m482,799514,277 93.9%   
No. of employees `000NANA-   
Total wages/salary Rs m34,50921,777 158.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m234,555152,652 153.7%  
Other income Rs m3,2262,354 137.0%   
Total revenues Rs m237,781155,006 153.4%   
Gross profit Rs m42,56634,427 123.6%  
Depreciation Rs m11,2657,130 158.0%   
Interest Rs m4861,270 38.3%   
Profit before tax Rs m34,04028,381 119.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,2565,117 141.8%   
Profit after tax Rs m26,78423,264 115.1%  
Gross profit margin %18.122.6 80.5%  
Effective tax rate %21.318.0 118.2%   
Net profit margin %11.415.2 74.9%  
BALANCE SHEET DATA
Current assets Rs m181,227122,614 147.8%   
Current liabilities Rs m81,56078,394 104.0%   
Net working cap to sales %42.529.0 146.7%  
Current ratio x2.21.6 142.1%  
Inventory Days Days2593 27.0%  
Debtors Days Days6280 78.2%  
Net fixed assets Rs m155,104144,382 107.4%   
Share capital Rs m5861,024 57.2%   
"Free" reserves Rs m245,174168,972 145.1%   
Net worth Rs m245,760169,996 144.6%   
Long term debt Rs m2,4923,621 68.8%   
Total assets Rs m336,331266,996 126.0%  
Interest coverage x71.023.3 304.0%   
Debt to equity ratio x00 47.6%  
Sales to assets ratio x0.70.6 122.0%   
Return on assets %8.19.2 88.2%  
Return on equity %10.913.7 79.6%  
Return on capital %13.917.1 81.4%  
Exports to sales %31.10-   
Imports to sales %11.914.3 83.2%   
Exports (fob) Rs m72,862NA-   
Imports (cif) Rs m27,96521,869 127.9%   
Fx inflow Rs m77,24563,065 122.5%   
Fx outflow Rs m31,52421,869 144.1%   
Net fx Rs m45,72141,196 111.0%   
CASH FLOW
From Operations Rs m50,16521,041 238.4%  
From Investments Rs m-32,11611,544 -278.2%  
From Financial Activity Rs m-29,693-8,683 342.0%  
Net Cashflow Rs m-11,67423,729 -49.2%  

Share Holding

Indian Promoters % 48.8 75.0 65.0%  
Foreign collaborators % 3.1 0.0 -  
Indian inst/Mut Fund % 37.2 16.2 229.5%  
FIIs % 22.3 2.5 888.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 25.0 192.5%  
Shareholders   369,828 370,396 99.8%  
Pledged promoter(s) holding % 17.2 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    LUPIN    LAURUS LABS     


More on Aurobindo Pharma vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Aurobindo Pharma vs Cadila Healthcare Share Price Performance

Period Aurobindo Pharma Cadila Healthcare S&P BSE HEALTHCARE
1-Day 6.32% -1.10% 1.20%
1-Month 0.83% 6.98% -3.18%
1-Year -31.53% 18.32% -7.59%
3-Year CAGR -6.36% 19.36% 16.43%
5-Year CAGR -5.86% 3.22% 9.40%

* Compound Annual Growth Rate

Here are more details on the Aurobindo Pharma share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of Aurobindo Pharma hold a 51.8% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Aurobindo Pharma and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, Aurobindo Pharma paid a dividend of Rs 9.0 per share. This amounted to a Dividend Payout ratio of 19.7%.

Cadila Healthcare paid Rs 2.5, and its dividend payout ratio stood at 11.0%.

You may visit here to review the dividend history of Aurobindo Pharma, and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Ends 378 Points Higher | Nifty Ends Above 17,850 | Paytm & Adani Enterprises Rally 15% Sensex Today Ends 378 Points Higher | Nifty Ends Above 17,850 | Paytm & Adani Enterprises Rally 15%(Closing)

After opening the day on a positive note, Indian share markets continued their momentum as the session progressed and ended higher.